Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9424 |
High Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.9034 |
High Similarity |
NPD4584 |
Approved |
0.8896 |
High Similarity |
NPD4010 |
Discontinued |
0.8792 |
High Similarity |
NPD4017 |
Approved |
0.8699 |
High Similarity |
NPD5241 |
Discontinued |
0.8675 |
High Similarity |
NPD4773 |
Phase 2 |
0.8675 |
High Similarity |
NPD4772 |
Phase 2 |
0.8662 |
High Similarity |
NPD2898 |
Approved |
0.8645 |
High Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.8533 |
High Similarity |
NPD3641 |
Approved |
0.8533 |
High Similarity |
NPD3640 |
Phase 3 |
0.8533 |
High Similarity |
NPD3639 |
Approved |
0.8523 |
High Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD7298 |
Approved |
0.8456 |
Intermediate Similarity |
NPD2421 |
Approved |
0.8456 |
Intermediate Similarity |
NPD2420 |
Approved |
0.8442 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD8054 |
Approved |
0.8415 |
Intermediate Similarity |
NPD8053 |
Approved |
0.8411 |
Intermediate Similarity |
NPD6030 |
Approved |
0.8411 |
Intermediate Similarity |
NPD6031 |
Approved |
0.8397 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.8397 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.8389 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.838 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.8322 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.8313 |
Intermediate Similarity |
NPD27 |
Approved |
0.8313 |
Intermediate Similarity |
NPD2489 |
Approved |
0.831 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD2969 |
Approved |
0.8137 |
Intermediate Similarity |
NPD2970 |
Approved |
0.8125 |
Intermediate Similarity |
NPD3144 |
Approved |
0.8125 |
Intermediate Similarity |
NPD3145 |
Approved |
0.8112 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.8108 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.8075 |
Intermediate Similarity |
NPD3051 |
Approved |
0.8067 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.8061 |
Intermediate Similarity |
NPD6297 |
Approved |
0.8038 |
Intermediate Similarity |
NPD2563 |
Approved |
0.8038 |
Intermediate Similarity |
NPD2560 |
Approved |
0.8037 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7988 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7987 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7974 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7973 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7973 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7947 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7939 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.7902 |
Intermediate Similarity |
NPD3053 |
Approved |
0.7902 |
Intermediate Similarity |
NPD3055 |
Approved |
0.7901 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7901 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD6851 |
Approved |
0.787 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7862 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7862 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7853 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.7843 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7834 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7812 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7811 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7811 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7811 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7811 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7811 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7811 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7811 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD3110 |
Approved |
0.777 |
Intermediate Similarity |
NPD3109 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7755 |
Intermediate Similarity |
NPD2028 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD2667 |
Approved |
0.773 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7727 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD824 |
Approved |
0.7712 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7703 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7703 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7674 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7671 |
Intermediate Similarity |
NPD3636 |
Approved |
0.7671 |
Intermediate Similarity |
NPD3637 |
Approved |
0.7671 |
Intermediate Similarity |
NPD3635 |
Approved |
0.766 |
Intermediate Similarity |
NPD4093 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7644 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7619 |
Intermediate Similarity |
NPD5313 |
Approved |
0.7613 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7597 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7597 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7586 |
Intermediate Similarity |
NPD5310 |
Approved |
0.7586 |
Intermediate Similarity |
NPD5311 |
Approved |
0.7582 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.758 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7571 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD5155 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5156 |
Approved |
0.7564 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD823 |
Approved |
0.755 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD817 |
Approved |
0.7548 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7533 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD1669 |
Approved |
0.75 |
Intermediate Similarity |
NPD3594 |
Approved |
0.75 |
Intermediate Similarity |
NPD2605 |
Approved |
0.75 |
Intermediate Similarity |
NPD7281 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD2606 |
Approved |
0.75 |
Intermediate Similarity |
NPD7280 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3595 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6687 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6688 |
Approved |
0.7484 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD7905 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD2226 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD228 |
Approved |
0.7436 |
Intermediate Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD7291 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7423 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7421 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD4104 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD4098 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD4103 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7399 |
Intermediate Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD4659 |
Approved |
0.7389 |
Intermediate Similarity |
NPD5160 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD4083 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD6364 |
Approved |
0.7372 |
Intermediate Similarity |
NPD44 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3920 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD7479 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD5720 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7357 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7355 |
Intermediate Similarity |
NPD3656 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1130 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1136 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1132 |
Approved |
0.7346 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6876 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6875 |
Approved |
0.7346 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7345 |
Intermediate Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD5303 |
Approved |
0.7343 |
Intermediate Similarity |
NPD5304 |
Approved |
0.7341 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD4873 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD598 |
Approved |
0.7285 |
Intermediate Similarity |
NPD597 |
Approved |
0.7285 |
Intermediate Similarity |
NPD601 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6523 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD1420 |
Approved |
0.7279 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7279 |
Intermediate Similarity |
NPD1421 |
Approved |
0.7268 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7268 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7268
|
Intermediate Similarity |
NPD3450 |
Approved |